BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 33279589)

  • 1. Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA Practical Guide.
    Capiau A; De Backer T; Grymonprez M; Lahousse L; Van Tongelen I; Mehuys E; Boussery K
    Int J Cardiol; 2021 Apr; 328():97-103. PubMed ID: 33279589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of Non-vitamin K Antagonist Oral Anticoagulants Dosing According to Different Prescription Guides Used in Belgian Ambulatory Care.
    Delesie M; Ballet A; Hillegeer C; Desteghe L; Dendale P; Heidbuchel H
    Clin Drug Investig; 2022 Sep; 42(9):775-786. PubMed ID: 35986867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation.
    Rymer JA; Chiswell K; Young L; Chiu A; Liu L; Webb L; Carlisle M; Friedman D; Wang TY
    JAMA Netw Open; 2023 Jun; 6(6):e2317156. PubMed ID: 37285155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriateness of DOAC Prescribing Before and During Hospital Admission and Analysis of Determinants for Inappropriate Prescribing.
    Moudallel S; Steurbaut S; Cornu P; Dupont A
    Front Pharmacol; 2018; 9():1220. PubMed ID: 30425641
    [No Abstract]   [Full Text] [Related]  

  • 5. Inappropriate direct oral anticoagulant prescriptions in patients with non-valvular atrial fibrillation: cross-sectional analysis of the French CACAO cohort study in primary care.
    Ferrat E; Fabre J; Galletout P; Boutin E; Le Breton J; Renard V; Frappé P; Bastuji-Garin S
    Br J Gen Pract; 2021; 71(703):e134-e139. PubMed ID: 33495204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Renal Function on Dosing of Non-Vitamin K Antagonist Direct Oral Anticoagulants Among Patients With Nonvalvular Atrial Fibrillation.
    Shrestha S; Baser O; Kwong WJ
    Ann Pharmacother; 2018 Feb; 52(2):147-153. PubMed ID: 28856898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards.
    De Vincentis A; Soraci L; Arena E; Sciacqua A; Armentaro G; Aucella F; Corsonello A; Aucella F; Antonelli Incalzi R
    Br J Clin Pharmacol; 2024 May; 90(5):1231-1239. PubMed ID: 38321367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior direct oral anticoagulant dosage and outcomes in patients with acute ischemic stroke and non-valvular atrial fibrillation: A sub-analysis of PASTA registry study.
    Mashiko T; Fujimoto S; Suda S; Abe A; Iguchi Y; Yagita Y; Kanzawa T; Okubo S; Todo K; Yamazaki M; Nakajima N; Kondo K; Inoue T; Iwanaga T; Terasawa Y; Shibazaki K; Kimura K;
    J Neurol Sci; 2022 Mar; 434():120163. PubMed ID: 35121210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates of Potentially Inappropriate Dosing of Direct-Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE-AF Study.
    Sanghai S; Wong C; Wang Z; Clive P; Tran W; Waring M; Goldberg R; Hayward R; Saczynski JS; McManus DD
    J Am Heart Assoc; 2020 Mar; 9(6):e014108. PubMed ID: 32146898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review.
    van der Horst SFB; van Rein N; van Mens TE; Huisman MV; Klok FA
    Thromb Res; 2023 Nov; 231():135-140. PubMed ID: 37005194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness of Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: Insights From the Veterans Health Administration.
    Leef GC; Perino AC; Askari M; Fan J; Ho PM; Olivier CB; Longo L; Mahaffey KW; Turakhia MP
    J Pharm Pract; 2020 Oct; 33(5):647-653. PubMed ID: 30791808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation.
    Carbone A; Santelli F; Bottino R; Attena E; Mazzone C; Parisi V; D'Andrea A; Golino P; Nigro G; Russo V
    Eur J Clin Pharmacol; 2022 May; 78(5):879-886. PubMed ID: 35138442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
    Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases.
    Huiart L; Ferdynus C; Renoux C; Beaugrand A; Lafarge S; Bruneau L; Suissa S; Maillard O; Ranouil X
    BMJ Open; 2018 Mar; 8(3):e018180. PubMed ID: 29602837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in anticoagulant prescribing: a review of local policies in English primary care.
    Ho KH; van Hove M; Leng G
    BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment.
    Ting C; Rhoten M; Dempsey J; Nichols H; Fanikos J; Ruff CT
    Clin Appl Thromb Hemost; 2021; 27():1076029620987900. PubMed ID: 33517715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriateness of direct oral anticoagulant dosing and its relation to drug levels in atrial fibrillation patients.
    Hirsh Raccah B; Rottenstreich A; Zacks N; Matok I; Danenberg HD; Pollak A; Kalish Y
    J Thromb Thrombolysis; 2019 May; 47(4):550-557. PubMed ID: 30689152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Haeusler KG; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
    Eur Heart J; 2018 Apr; 39(16):1330-1393. PubMed ID: 29562325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study.
    Miyazaki M; Matsuo K; Uchiyama M; Nakamura Y; Sakamoto Y; Misaki M; Tokura K; Jimi S; Okamura K; Adachi S; Yamamoto T; Shirai K; Urata H; Imakyure O
    J Pharm Health Care Sci; 2020; 6():2. PubMed ID: 32071730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
    Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.